The point that I still don't want us to lose is that a specific scientific finding has a determinable status, a level of quality or usefulness, for which there may be proxies, like consensus or citations. The idea that a finding has a status shouldn't be controversial. But it is the issue that is implicitly or explicitly avoided in many posts. It seems to me that there is a deep discomfort and aversion to the idea that a scientific point can have a status. That's my worry - it is an open question that shouldn't exist here.
Again, I'm still looking for agreement without dispute that a scientific idea or observation can have a status.... Agreement with that first point still seems to be up in the air.
I confess I'm getting a bit tangled up trying to follow your argument, but here are a few thoughts for you to pick apart if you wish. It is very likely that I have completely missed the point.
A scientific idea, like the BPS model for ME, has a 'status' that is built on consensus within a specific group of researchers. It has a 'status' that is built on number of research papers and citations. It has a 'status' that is built on usefulness to health funding authorities. It has a 'status' that is built on the eminence of some of the researchers.
But it is also a pile of crap.
It should have very low scientific status because the research methods are so poor and the findings so weak.
............
'Status' if you want to call it that for research on basic science related to ME, such as metabolomics, should be built on robustness of findings, replicability, size of studies, etc. The 2 day CPET findings seem to be reaching that level with several centres publishing results of studies. I can't think of any other biomedical findings that are both robust and sufficiently replicated yet.
And 'status' of research on treatments should be based on the level of research evidence available,
- starting at the lowest level with anecdote: individual stories or small case studies, in which low status I would include ME specialists using what 'seems to help' their patients;
- working up through unblinded pilot studies which are only useful as an indicator that more research might be warranted;
- all the way to large scale multi centre double blinded placebo controlled trials with clear and clinically significant robust findings having the highest status.
.........
I think the problem so far with ME research is that almost all done so far is quite low status, largely because, due to lack of funding, studies have been too small and haven't been replicated, and clinical trials of treatments have only been at pilot study level if that, apart from Rituximab which didn't work.